A large pharmaceutical company had to recall a batch of its widely-used chewable birth control tablets after a packaging error potentially rendered the pills ineffective if taken.
In late May, Lupin Pharmaceuticals and the Food and Drug Administration announced that users taking Mibelas 24 Fe should return the product and seek out a new prescription after discovering that a batch of pills didn’t have the correct sequence of hormonal versus non-hormonal tablets. In the botched batch, there were four non-hormonal placebo pills placed at the beginning of each “treatment” (i.e. month) as opposed to just at the end of the treatment. The FDA warned that if the pills are ingested in the usual order, the incorrect sequencing could lead to unintended pregnancy. Additionally, the FDA reported that it’s possible the recalled pills could lead to issues with maternal and fetal health if a pregnancy develops, although the department noted that it hadn’t received any reports of these negative effects yet.
For Mibelas users wondering if their pills are part of the recall, the lot number is L600518 and the expiration date is May 2018, though one of the reported packaging errors for some of the pills was that these numbers couldn’t be found on the packaging. Mibelas users should also notify their physicians and return the birth control pills to the pharmacy or medical center where they received them.
Any questions about the recalled pills can be directed to Lupin Pharmaceuticals at 800-399-2561.
More on sex and contraception:
- Rubber Robbers Steal 30,000 Condoms and $10,000 of Sex Toys
- Removing a Condom Without Consent Isn’t Just Wrong — It’s Assault
- Here’s the Problem With Saying There Are 5 Types of Vaginas